These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 11578811)
21. Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma. Guo W; Zhang M; Shen S; Guo Y; Kuang G; Yang Z; Dong Z Cancer; 2014 Aug; 120(16):2412-23. PubMed ID: 24798237 [TBL] [Abstract][Full Text] [Related]
22. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Yoshiura K; Kanai Y; Ochiai A; Shimoyama Y; Sugimura T; Hirohashi S Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7416-9. PubMed ID: 7543680 [TBL] [Abstract][Full Text] [Related]
23. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Yamashita K; Upadhyay S; Osada M; Hoque MO; Xiao Y; Mori M; Sato F; Meltzer SJ; Sidransky D Cancer Cell; 2002 Dec; 2(6):485-95. PubMed ID: 12498717 [TBL] [Abstract][Full Text] [Related]
24. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development. Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858 [TBL] [Abstract][Full Text] [Related]
25. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma. Kao RH; Huang LC; Hsu YH Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040 [TBL] [Abstract][Full Text] [Related]
26. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer. Ribeiro-Filho LA; Franks J; Sasaki M; Shiina H; Li LC; Nojima D; Arap S; Carroll P; Enokida H; Nakagawa M; Yonezawa S; Dahiya R Mol Carcinog; 2002 Aug; 34(4):187-98. PubMed ID: 12203370 [TBL] [Abstract][Full Text] [Related]
27. The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas. Chan SL; Cui Y; van Hasselt A; Li H; Srivastava G; Jin H; Ng KM; Wang Y; Lee KY; Tsao GS; Zhong S; Robertson KD; Rha SY; Chan AT; Tao Q Lab Invest; 2007 Jul; 87(7):644-50. PubMed ID: 17384664 [TBL] [Abstract][Full Text] [Related]
28. Aberrant promoter methylation of the TPEF gene in esophageal squamous cell carcinoma. Zhao BJ; Tan SN; Cui Y; Sun DG; Ma X Dis Esophagus; 2008; 21(7):582-8. PubMed ID: 19040536 [TBL] [Abstract][Full Text] [Related]
29. [Study on promoter methylation status of E-cadherin gene in nasopharyngeal carcinoma cell lines]. Hong CQ; Ran YG; Chen JY; Wu X; You YJ Zhonghua Bing Li Xue Za Zhi; 2010 Aug; 39(8):532-6. PubMed ID: 21055032 [TBL] [Abstract][Full Text] [Related]
30. Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer. Mostafavi-Pour Z; Kianpour S; Dehghani M; Mokarram P; Torabinejad S; Monabati A Pathol Oncol Res; 2015 Sep; 21(4):921-7. PubMed ID: 25743258 [TBL] [Abstract][Full Text] [Related]
31. Frequent hypermethylation of the 5' CpG island of E-cadherin in esophageal adenocarcinoma. Corn PG; Heath EI; Heitmiller R; Fogt F; Forastiere AA; Herman JG; Wu TT Clin Cancer Res; 2001 Sep; 7(9):2765-9. PubMed ID: 11555590 [TBL] [Abstract][Full Text] [Related]
32. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer. Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473 [TBL] [Abstract][Full Text] [Related]
33. Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma. Yang XX; Sun JZ; Li FX; Wu YS; Du HY; Zhu W; Li XH; Li M World J Gastroenterol; 2012 Jun; 18(21):2719-26. PubMed ID: 22690083 [TBL] [Abstract][Full Text] [Related]
34. Reduced T-cadherin expression and promoter methylation are associated with the development and progression of hepatocellular carcinoma. Yan Q; Zhang ZF; Chen XP; Gutmann DH; Xiong M; Xiao ZY; Huang ZY Int J Oncol; 2008 May; 32(5):1057-63. PubMed ID: 18425332 [TBL] [Abstract][Full Text] [Related]
35. Aberrant methylation of the 3q25 tumor suppressor gene PTX3 in human esophageal squamous cell carcinoma. Wang JX; He YL; Zhu ST; Yang S; Zhang ST World J Gastroenterol; 2011 Oct; 17(37):4225-30. PubMed ID: 22072855 [TBL] [Abstract][Full Text] [Related]
36. Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer. Dong Z; Zhang A; Liu S; Lu F; Guo Y; Zhang G; Xu F; Shi Y; Shen S; Liang J; Guo W Mol Cancer Res; 2017 Jul; 15(7):800-810. PubMed ID: 28539329 [TBL] [Abstract][Full Text] [Related]
37. Epigenetic inactivation of the SFRP1 gene in esophageal squamous cell carcinoma. Meng Y; Wang QG; Wang JX; Zhu ST; Jiao Y; Li P; Zhang ST Dig Dis Sci; 2011 Nov; 56(11):3195-203. PubMed ID: 21567192 [TBL] [Abstract][Full Text] [Related]
39. Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma. Tao J; Liu Q; Wu X; Xu X; Zhang Y; Wang Q; Luo C Int J Med Sci; 2013; 10(13):1860-7. PubMed ID: 24324362 [TBL] [Abstract][Full Text] [Related]
40. Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]